AMN Healthcare (AMN) has released its Q2 earnings. Here is a breakdown of the information AMN Healthcare presented to its investors.

AMN Healthcare Services, Inc. is a leading provider of total talent solutions for healthcare organizations across the United States, offering a comprehensive network of healthcare professionals and workforce technologies. 

In the second quarter of 2025, AMN Healthcare reported a revenue of $658 million and an adjusted EBITDA of $58.3 million. Despite a GAAP loss of $3.02 per share, the company achieved an adjusted EPS of $0.30. 

Key financial highlights include a decrease in revenue by 11% year-over-year and a significant GAAP loss due to non-cash goodwill and intangible asset impairment charges. The Nurse and Allied Solutions segment saw a 14% decline in revenue, while the Physician and Leadership Solutions segment experienced a 6% drop. The company also reported strong cash flow from operations, allowing a reduction in debt by $80 million. 

Looking ahead, AMN Healthcare anticipates a challenging third quarter with projected revenue declines across all segments. However, the company remains optimistic about its strategic initiatives and technology advancements, positioning itself to capture future market share despite an uncertain healthcare policy environment.

AMN Healthcare Reports Q2 2025 Financial Results

AMN Healthcare (AMN) released Q2 2025 financial results, reporting $658 million in revenue and $58.3 million in adjusted EBITDA. The company faced a GAAP loss of $3.02 per share but achieved an adjusted EPS of $0.30. Revenue declined 11% YoY, with the Nurse and Allied Solutions segment down 14% and the Physician and Leadership Solutions segment down 6%. Strong cash flow reduced debt by $80 million, though the company anticipates a challenging Q3 with projected revenue declines. Strategic initiatives and technology advancements remain central to its outlook.